Corcept Therapeutics (CORT) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $110.29 -3.98%
Revenue Growth %: +56.0%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +56.0%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.5 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Redburn upgrades Southwest, stays bullish on Delta and United
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
